OZEM vs. CNCR ETF Comparison
Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to Loncar Cancer Immunotherapy ETF (CNCR)
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.
Grade (RS Rating)
Last Trade
$27.19
Average Daily Volume
27,613
6
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$14.95
Average Daily Volume
4,117
67
Performance
| Period | OZEM | CNCR |
|---|---|---|
| 30 Days | -3.44% | 3.21% |
| 60 Days | 5.67% | 9.36% |
| 90 Days | 0.26% | 12.83% |
| 12 Months | 39.07% |
0 Overlapping Holdings
| Symbol | Grade | Weight in OZEM | Weight in CNCR | Overlap |
|---|
OZEM Underweight 67 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| SMMT | D | -6.18% | |
| GERN | D | -3.67% | |
| ELVN | A | -2.94% | |
| IGMS | C | -2.34% | |
| NRIX | D | -2.31% | |
| FHTX | C | -2.18% | |
| ACRV | F | -1.99% | |
| RVMD | B | -1.94% | |
| TYRA | C | -1.85% | |
| ERAS | D | -1.81% | |
| BNTX | B | -1.79% | |
| REPL | C | -1.78% | |
| TSVT | C | -1.75% | |
| KYMR | D | -1.73% | |
| JANX | C | -1.72% | |
| AURA | C | -1.7% | |
| ACLX | C | -1.67% | |
| NUVL | B | -1.65% | |
| EXEL | B | -1.61% | |
| HCM | B | -1.6% | |
| REGN | D | -1.53% | |
| NUVB | F | -1.53% | |
| MRUS | D | -1.51% | |
| BPMC | F | -1.48% | |
| CGEM | F | -1.43% | |
| BCYC | D | -1.42% | |
| DAWN | D | -1.4% | |
| ITOS | F | -1.38% | |
| IMTX | F | -1.37% | |
| BMY | A | -1.36% | |
| MRK | F | -1.33% | |
| IMRX | D | -1.29% | |
| XNCR | D | -1.29% | |
| RLAY | F | -1.28% | |
| KURA | F | -1.25% | |
| STRO | F | -1.23% | |
| IPHA | F | -1.23% | |
| YMAB | C | -1.21% | |
| GLUE | F | -1.19% | |
| RCUS | D | -1.18% | |
| SNDX | F | -1.17% | |
| GMAB | F | -1.13% | |
| LEGN | F | -1.05% | |
| SDGR | F | -1.02% | |
| ACET | F | -0.98% | |
| IDYA | F | -0.97% | |
| LYEL | F | -0.96% | |
| IOVA | D | -0.95% | |
| RPTX | D | -0.93% | |
| PGEN | F | -0.93% | |
| SWTX | F | -0.92% | |
| ALLO | D | -0.91% | |
| RXRX | F | -0.91% | |
| AUTL | D | -0.9% | |
| BMEA | D | -0.83% | |
| ARVN | F | -0.78% | |
| KPTI | D | -0.76% | |
| IMCR | F | -0.73% | |
| FATE | F | -0.69% | |
| PRLD | F | -0.67% | |
| VOR | F | -0.54% | |
| CRBU | F | -0.52% | |
| MRSN | D | -0.52% | |
| GNLX | D | -0.49% | |
| ZNTL | F | -0.37% | |
| RAPT | F | -0.33% | |
| MGNX | F | -0.28% |
OZEM: Top Represented Industries & Keywords
CNCR: Top Represented Industries & Keywords
Compare ETFs
